Literature DB >> 20697407

The expanding family of dendritic cell subsets.

Hideki Ueno, A Karolina Palucka, Jacques Banchereau.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20697407     DOI: 10.1038/nbt0810-813

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  16 in total

Review 1.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.

Authors:  Yong-Jun Liu
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 2.  The CD8+ dendritic cell subset.

Authors:  Ken Shortman; William R Heath
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

3.  The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.

Authors:  Irina Caminschi; Anna I Proietto; Fatma Ahmet; Susie Kitsoulis; Joo Shin Teh; Jennifer C Y Lo; Alexandra Rizzitelli; Li Wu; David Vremec; Serani L H van Dommelen; Ian K Campbell; Eugene Maraskovsky; Hal Braley; Gayle M Davey; Patricia Mottram; Nicholas van de Velde; Kent Jensen; Andrew M Lew; Mark D Wright; William R Heath; Ken Shortman; Mireille H Lahoud
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

4.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.

Authors:  Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

5.  Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.

Authors:  Annabell Bachem; Steffen Güttler; Evelyn Hartung; Frédéric Ebstein; Michael Schaefer; Astrid Tannert; Abdulgabar Salama; Kamran Movassaghi; Corinna Opitz; Hans W Mages; Volker Henn; Peter-Michael Kloetzel; Stephanie Gurka; Richard A Kroczek
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

6.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

7.  Plasmacytoid dendritic cells mediate oral tolerance.

Authors:  Anne Goubier; Bertrand Dubois; Hanane Gheit; Grégoire Joubert; Florence Villard-Truc; Carine Asselin-Paturel; Giorgio Trinchieri; Dominique Kaiserlian
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

8.  Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Authors:  Eynav Klechevsky; Rimpei Morita; Maochang Liu; Yanying Cao; Sebastien Coquery; Luann Thompson-Snipes; Francine Briere; Damien Chaussabel; Gerard Zurawski; A Karolina Palucka; Yoram Reiter; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

9.  Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

Authors:  David Sancho; Diego Mourão-Sá; Olivier P Joffre; Oliver Schulz; Neil C Rogers; Daniel J Pennington; James R Carlyle; Caetano Reis e Sousa
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

10.  In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.

Authors:  Laura C Bonifaz; David P Bonnyay; Anna Charalambous; Dara I Darguste; Shin-Ichiro Fujii; Helena Soares; Marie K Brimnes; Bruno Moltedo; Thomas M Moran; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

View more
  14 in total

1.  Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses.

Authors:  Wen-Chun Liu; Shih-Chang Lin; Yen-Ling Yu; Ching-Liang Chu; Suh-Chin Wu
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

Review 2.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge.

Authors:  Jennifer L Yates; Rachael Racine; Kevin M McBride; Gary M Winslow
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

Review 4.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

Review 5.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

6.  Lung dendritic cells at the innate-adaptive immune interface.

Authors:  Tracy Voss Condon; Richard T Sawyer; Matthew J Fenton; David W H Riches
Journal:  J Leukoc Biol       Date:  2011-08-01       Impact factor: 4.962

Review 7.  CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic.

Authors:  Basav N Hangalapura; Laura Timares; Dinja Oosterhoff; Rik J Scheper; David T Curiel; Tanja D de Gruijl
Journal:  J Gene Med       Date:  2012-06       Impact factor: 4.565

Review 8.  Recent developments in cancer vaccines.

Authors:  Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  J Immunol       Date:  2011-02-01       Impact factor: 5.422

9.  Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Wolf Hervé Fridman; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-05-01       Impact factor: 8.110

10.  Harnessing dendritic cells for tumor antigen presentation.

Authors:  Stefan Nierkens; Edith M Janssen
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.